To the best of our knowledge, this is the first study comparing D-dimer levels to smoking status, antiplatelet treatment and anticoagulative treatment in COPD patients; we found that D-dimer levels were significantly higher among patients with concomitant P2Y12-inhibitor treatment. The gene discussed is P2RY12; the disease is chronic obstructive pulmonary disease.